YOCHAI BIRNBAUM to Cardiovascular Diseases
This is a "connection" page, showing publications YOCHAI BIRNBAUM has written about Cardiovascular Diseases.
Connection Strength
2.462
-
When Is It Appropriate to Publish a Meta-Analysis in Cardiovascular Drugs and Therapy? Cardiovasc Drugs Ther. 2023 06; 37(3):599-601.
Score: 0.325
-
Antacid Therapy in Coronary Artery Disease and Heart Failure: Proton Pump Inhibitors vs. H2 Receptor Blockers. Cardiovasc Drugs Ther. 2024 Feb; 38(1):181-189.
Score: 0.310
-
What Should Be Done With the Asymptomatic Patient With Right Bundle Branch Block? J Am Heart Assoc. 2020 10 20; 9(19):e018987.
Score: 0.274
-
Introduction and Vision. Cardiovasc Drugs Ther. 2020 02; 34(1):1-2.
Score: 0.263
-
GLP-1 Receptor Agonists and Cardiovascular Disease: a Meta-Analysis of Recent Cardiac Outcome Trials. Cardiovasc Drugs Ther. 2018 02; 32(1):65-72.
Score: 0.229
-
Electrocardiographic risk stratification of asymptomatic population without cardiovascular disease: Should we add the QRS-T angle? J Electrocardiol. 2017 Sep - Oct; 50(5):543-544.
Score: 0.219
-
Type 2 diabetes and cardiovascular disease: A metabolic overview of recent clinical trials. J Diabetes Complications. 2017 02; 31(2):291-294.
Score: 0.208
-
Modulation of eicosanoid production and activity as a potential explanation for some of the pleiotropic effects of statins. Cardiology. 2010; 116(1):45-7.
Score: 0.134
-
Pretreatment with statins may reduce cardiovascular morbidity and mortality after elective surgery and percutaneous coronary intervention: clinical evidence and possible underlying mechanisms. Am Heart J. 2007 Aug; 154(2):391-402.
Score: 0.110
-
The cycloxygenase 2 (COX-2) story: it's time to explain, not inflame. J Cardiovasc Pharmacol Ther. 2007 Jun; 12(2):98-111.
Score: 0.109
-
Understanding gastrointestinal bleeding in patients with cardiac disease: an interdisciplinary approach. Expert Rev Cardiovasc Ther. 2025 Apr-May; 23(5):197-207.
Score: 0.096
-
Utilization Rates of SGLT2 Inhibitors and GLP-1 Receptor Agonists and Their Facility-Level Variation Among Patients With Atherosclerotic Cardiovascular Disease and Type 2 Diabetes: Insights From the Department of Veterans Affairs. Diabetes Care. 2022 02 01; 45(2):372-380.
Score: 0.075
-
Highlights from Selected Cardiovascular Disease Prevention Studies Presented at the 2019 European Society of Cardiology Congress. Curr Atheroscler Rep. 2019 11 19; 21(12):46.
Score: 0.065
-
GLP1-RA and SGLT2-i: Implementation and Insulin Deescalation Strategies. Cardiovasc Drugs Ther. 2026 Apr; 40(2):779-793.
Score: 0.024
-
Rapid screening of cardiac patients with a miniaturized hand-held ultrasound imager--comparisons with physical examination and conventional two-dimensional echocardiography. Clin Cardiol. 2004 Apr; 27(4):241-5.
Score: 0.022